PHARMA-BIO SERV, INC. Accounts Receivable, Allowance for Credit Loss
PHARMA-BIO SERV, INC. (PBSV) had Accounts Receivable, Allowance for Credit Loss of $5.30 million as of 2026-07-31, per its 10-Q filed 2026-09-14.
Financial Statements › Balance Sheet › Assets › Accounts Receivable, after Allowance for Credit Loss
us-gaap:AllowanceForDoubtfulAccountsReceivable · last filed 2026-09-14
- 2026-07-31: Accounts Receivable, Allowance for Credit Loss $5.30M.
- 2026-04-30: Accounts Receivable, Allowance for Credit Loss $5.30M.
- 2026-01-31: Accounts Receivable, Allowance for Credit Loss $5.30M.
- 2025-10-31: Accounts Receivable, Allowance for Credit Loss $5.30M.
| Period end | Accounts Receivable, Allowance for Credit Loss |
|---|---|
| 2026-07-31 | $5.30M 10-Q · filed 2026-09-14 |
| 2026-04-30 | $5.30M 10-Q · filed 2026-06-15 |
| 2026-01-31 | $5.30M 10-Q · filed 2026-03-17 |
| 2025-10-31 | $5.30M 10-Q · filed 2026-09-14 |
| 2025-07-31 | $5.30M 10-Q · filed 2025-09-15 |